Auditory Slow Wave Enhancement After Concussion
The Effect of Sleep and Slow Wave Enhancement on Recovery From a Concussion in Children and Adolescents: A Longitudinal, Randomized, Double-Blind, and Sham-Controlled Study
1 other identifier
interventional
120
1 country
1
Brief Summary
The prevalence of a traumatic brain injury (TBI) in children and adolescents is around 30% with 70-90% being classified as mild (concussion). Because the brain of a child is still developing, a TBI can have devastating effects and possibly creates lifetime challenges. Sleep seems to play an important role in the post-concussion recovery process. Auditory stimulation during sleep has been shown to reliably boost slow waves, a solid marker for the depth of sleep, and can thus be used to deepen sleep. This study aims to investigate the effects of sleep enhancement via auditory stimulation on recovery after a concussion in children and adolescents in their home. Therefore, half of the patients receive one week of auditory stimulation during deep sleep at their home using a mobile device. The other half follows the same study protocol, but no tones are administered (sham). Cognitive tests as well as symptom questionnaires are used to assess the recovery process. It is hypothesized that the patients in the intervention group will recover better than the ones who haven't received the intervention. Additionally, a group of children and adolescents who never sustained a concussion is included as a control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2021
CompletedFirst Posted
Study publicly available on registry
February 25, 2021
CompletedStudy Start
First participant enrolled
May 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedDecember 9, 2024
December 1, 2024
4.8 years
February 16, 2021
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cognitive Performance - attention
Assessed by standardized test (normative values).
Measured one month after study inclusion.
Cognitive Performance - processing speed
Assessed by standardized test (normative values).
Measured one month after study inclusion.
Cognitive Performance - executive function
Assessed by standardized test (normative values).
Measured one month after study inclusion.
Secondary Outcomes (11)
Subjective recovery
Measured at baseline, one week later (intermediate assessment), one month later (follow-up 1) and six months later (follow-up 2).
Algorithm performance
Recorded during seven nights of stimulation or sham (intervention week).
Neurological outcome
One month after study inclusion (follow-up 1).
Injury characteristics
baseline, pre-intervention
Other possible moderators of the Intervention
Collected at the baseline assessment.
- +6 more secondary outcomes
Other Outcomes (1)
Intervention tolerability
After the intervention week (one week after study inclusion).
Study Arms (2)
Intervention group
EXPERIMENTALParticipants in this group will receive all-night auditory stimulation during sleep over one week using a portable, in-home device (MHSL-SleepBand).
Control group
SHAM COMPARATORParticipants in this group will receive sham-stimulation, i.e. the device will be applied (biosignals will be recorded), but no tones will be played.
Interventions
The device records biosignals and precisely plays tones to enhance sleep slow waves.
Eligibility Criteria
You may qualify if:
- Informed Consent as documented by signature
- Age between 6 and 18 years
- Good knowledge of German of the patient and at least one legal representative
- Patients: Presentation to the Emergency of the University Children's Hospital Zurich because of a concussion (diagnosed by medical doctor)
You may not qualify if:
- Preterm birth (\< 37 gestational weeks)
- Diagnosed hearing disorder
- Psychiatric, syndromal, or neurological pre-existing condition (except for previous concussion)
- Skin disorder/skin problem in the face/ear area that requires Treatment
- Usage of neuroactive substances
- Patients: Concomitant injury that requires intense pain medication or a prolonged hospital stay, or that causes limited use of the dominant Hand
- Patients: Previous moderate-severe TBI
- Controls: Injury of the dominant hand, on head, arm, or leg
- Controls: Previous TBI (of any severity)
- Age at least 8 years
- Fulfilment of all MRI safety criteria
- The participant and the legal representative would want to know about incidental findings.
- Girls: No pregnancy or breast feeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Children's Hospital, Zurichlead
- ETH Zurichcollaborator
- University of Zurichcollaborator
Study Sites (1)
University Children's Hospital Zurich
Zurich, 8032, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Reto Huber, Prof.
University Children's Hospital, Zurich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Study helpers
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2021
First Posted
February 25, 2021
Study Start
May 31, 2021
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
December 9, 2024
Record last verified: 2024-12